Medical Updates

2023 Funding Updates

2023 Funding Updates

Published: May 20, 2024   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

With your support in 2023, we were able to fund 6 new individual researchers with grants of $225,000 each as well as co-funding with The Mark Foundation for Cancer Research 2 new collaborative research teams with grants of $500,000 each. Our grants are chosen by our outstanding Medical Advisory Board, assuring that the money that […]

Read more
2023 Medical Research Awards

2023 Medical Research Awards

Published: May 20, 2024   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period. We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! Stay tuned for spotlights on each grantee and their work throughout the rest of the […]

Read more
Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Sarah Tasian 

Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Sarah Tasian 

Published: Dec 13, 2023   |   Author: Michele Keene   |   Category: Medical Updates, What's New   |   No Comments

We are delighted to welcome Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Sarah K Tasian, MD is a pediatric oncologist and physician-scientist at the Children’s Hospital of Philadelphia (CHOP) and an Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine who is interested in […]

Read more
A membrane-associated MHC-I inhibitory axis for cancer immune evasion

A membrane-associated MHC-I inhibitory axis for cancer immune evasion

Published: Dec 7, 2023   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

From the lab of Gabrielle’s Angels grantee Iannis Aifantis – their latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such as acute myeloid leukemia (AML), do not respond or […]

Read more
Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants

Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants

Published: Nov 27, 2023   |   Author: Michele Keene   |   Category: Medical Updates, What's New   |   No Comments

We are thrilled to announce that we have selected the recipients of our first ever Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants. Co-funded with the Mark Foundation for Cancer Research, these two projects totaling $1M represent an amazing opportunity for us to re-invest in our grantees’ impactful work while helping to accelerate progress by bringing together scientists and institutions for collaboration. We are so grateful for […]

Read more
Dana-Farber physician Zuzana Tothova receives Doris Duke Foundation Paragon Award for Research Excellence

Dana-Farber physician Zuzana Tothova receives Doris Duke Foundation Paragon Award for Research Excellence

Published: Nov 27, 2023   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

Congratulations to Zuzana Tothova, MD, PhD (Gabrielle’s Angels Grantee 2022) who is the recipient of the Doris Duke Foundation‘s Paragon Award for Research Excellence! This one-time recognition honors physician-scientists who have significantly advanced knowledge toward the prevention, diagnosis, and treatment of human disease or who have, through their professional contributions, improved the health outcomes of […]

Read more
Revolutionary Assay Could Transform Acute Myeloid Leukemia Care

Revolutionary Assay Could Transform Acute Myeloid Leukemia Care

Published: Nov 13, 2023   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier. This assay may improve detection of AML driven by KMT2A gene fusions and may affect treatment decision-making, assessing response […]

Read more
Gabrielle’s Angels Grantee Dr. Daniel Herranz receives $800,000 grant for leukemia research

Gabrielle’s Angels Grantee Dr. Daniel Herranz receives $800,000 grant for leukemia research

Published: Nov 2, 2023   |   Author: Michele Keene   |   Category: Medical Updates   |   No Comments

Daniel Herranz Benito, an associate professor in the Department of Pharmacology, recently received an $800,000 grant from the V Foundation for Cancer Research to further research T cell Acute Lymphoblastic Leukemia (T-ALL). Benito, who is also a resident researcher at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Barnabas Health, said this four-year grant will allow him […]

Read more
2022 Research Grants

2022 Research Grants

Published: Sep 8, 2023   |   Author: Michele Keene   |   Category: Medical Updates, What's New   |   No Comments

Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period. We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! Stay tuned for spotlights on each grantee and their work throughout the […]

Read more
Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Eirini Papapetrou

Gabrielle’s Angel Foundation welcomes new Medical Advisory Board member Dr. Eirini Papapetrou

Published: May 8, 2023   |   Author: Jason Butler   |   Category: Medical Updates   |   No Comments

We are delighted to welcome Dr. Eirini Papapetrou to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research!  Dr. Papapetrou  is a Professor of Oncological Sciences, Hematology and Medical Oncology and founding Director of the Center for Advancement of Blood Cancer Therapies at the Icahn School of Medicine at Mount Sinai. She obtained MD and […]

Read more